1.30
price up icon0.78%   0.01
 
loading
Precedente Chiudi:
$1.29
Aprire:
$1.25
Volume 24 ore:
67,172
Relative Volume:
0.80
Capitalizzazione di mercato:
$54.10M
Reddito:
-
Utile/perdita netta:
$-14.47M
Rapporto P/E:
-1.0484
EPS:
-1.24
Flusso di cassa netto:
$-12.19M
1 W Prestazione:
-7.14%
1M Prestazione:
-27.78%
6M Prestazione:
-41.96%
1 anno Prestazione:
-52.03%
Intervallo 1D:
Value
$1.25
$1.33
Intervallo di 1 settimana:
Value
$1.17
$1.38
Portata 52W:
Value
$1.17
$3.48

Heartbeam Inc Stock (BEAT) Company Profile

Name
Nome
Heartbeam Inc
Name
Telefono
408-899-4443
Name
Indirizzo
2118 WALSH AVE., SUITE 210, SANTA CLARA
Name
Dipendente
19
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
BEAT's Discussions on Twitter

Confronta BEAT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
BEAT
Heartbeam Inc
1.30 54.10M 0 -14.47M -12.19M -1.24
Health Information Services icon
VEEV
Veeva Systems Inc
284.29 46.43B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
60.97 12.01B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
61.69 10.79B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
102.16 9.27B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
39.34 7.03B 906.14M -52.62M 89.62M -0.3621

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-09-11 Iniziato Needham Buy
2020-09-02 Iniziato Robert W. Baird Neutral
2020-01-08 Iniziato SunTrust Buy
2019-08-02 Downgrade Raymond James Outperform → Mkt Perform
2019-04-26 Reiterato Dougherty & Company Buy
2018-07-26 Reiterato Lake Street Buy
2018-04-26 Reiterato The Benchmark Company Buy
2018-02-23 Reiterato Dougherty & Company Buy
2017-11-08 Reiterato Dougherty & Company Buy
2017-10-26 Iniziato Raymond James Outperform
2017-10-24 Iniziato SunTrust Buy
2017-08-09 Reiterato Dougherty & Company Buy
2017-07-19 Reiterato The Benchmark Company Buy
2017-04-11 Reiterato Dougherty & Company Buy
2016-12-02 Iniziato Dougherty & Company Buy
2016-09-13 Iniziato Sidoti Buy
2016-08-03 Reiterato The Benchmark Company Buy
2015-07-28 Reiterato Dougherty & Company Buy
2013-10-24 Iniziato The Benchmark Company Buy
2013-08-21 Iniziato Dougherty & Company Buy
Mostra tutto

Heartbeam Inc Borsa (BEAT) Ultime notizie

pulisher
Jun 18, 2025

HeartBeam (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

IBN Coverage: HeartBeam (NASDAQ: BEAT) Is One to Watch - Yahoo Finance

Jun 17, 2025
pulisher
Jun 17, 2025

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025 - Business Wire

Jun 17, 2025
pulisher
Jun 17, 2025

BEAT Stock: A Comprehensive Analysis and Forecast - investchronicle.com

Jun 17, 2025
pulisher
Jun 16, 2025

HeartBeam Inc. Pioneers Cable-Free 12-Lead ECG System for At-Home Cardiac Monitoring - citybuzz -

Jun 16, 2025
pulisher
Jun 16, 2025

HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG - citybuzz -

Jun 16, 2025
pulisher
Jun 16, 2025

HeartBeam (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG - financial-news.co.uk

Jun 16, 2025
pulisher
Jun 13, 2025

HeartBeam Inc. Advances Toward Commercialization with Promising Q1 2025 Results - citybuzz -

Jun 13, 2025
pulisher
Jun 13, 2025

Here's Why HeartBeam (NASDAQ:BEAT) Must Use Its Cash Wisely - Yahoo Finance

Jun 13, 2025
pulisher
May 27, 2025

HeartBeam CEO Named to Company’s Board of Directors - Medical Product Outsourcing

May 27, 2025
pulisher
May 17, 2025

Benchmark maintains $8 target on Heartbeam stock post-1Q report - Investing.com Australia

May 17, 2025
pulisher
May 16, 2025

Benchmark maintains $8 target on Heartbeam stock post-1Q report By Investing.com - Investing.com India

May 16, 2025
pulisher
May 15, 2025

HeartBeam’s Positive Earnings Call Reflects Growth Potential - TipRanks

May 15, 2025
pulisher
May 15, 2025

HeartBeam, Inc. (NASDAQ:BEAT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 15, 2025
pulisher
May 14, 2025

HeartBeam (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update - Barchart.com

May 14, 2025
pulisher
May 14, 2025

HeartBeam (BEAT) Reports Advancements in Q1 2025 | BEAT Stock Ne - GuruFocus

May 14, 2025
pulisher
May 14, 2025

HeartBeam reports net loss of USD 5.5M in Q1 2025 - Medical Buyer

May 14, 2025
pulisher
May 14, 2025

HeartBeam, Inc. Reports Q1 2025 Financial Results - TipRanks

May 14, 2025
pulisher
May 13, 2025

Earnings call transcript: HeartBeam Q1 2025 miss doesn’t deter investors By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Heartbeam Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

HeartBeam Q1 2025 slides: FDA progress and commercial readiness amid continued losses - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

HeartBeam, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

HeartBeam Reports First Quarter 2025 Results - Business Wire

May 13, 2025
pulisher
May 09, 2025

The Week in Canadian Press Releases: 10 Stories You Need to See - The Globe and Mail

May 09, 2025
pulisher
May 07, 2025

HeartBeam strengthens IP with US patents for cardiac monitoring - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

Two New U.S. Patents Bring Total to 20 Issued Worldwide, - openPR.com

May 06, 2025
pulisher
May 06, 2025

Two New U.S. Patents Bring Total to 20 Issued Worldwide, Cementing Company Leadership in Cardiac Monitoring Innovation for 12-Lead ECG Synthesis Technology: HeartBeam, Inc. (Nasdaq: BEAT) - Barchart.com

May 06, 2025
pulisher
May 06, 2025

HeartBeam Secures 2 New U.S. Patents - Medical Product Outsourcing

May 06, 2025
pulisher
May 06, 2025

HeartBeam (NASDAQ: BEAT) Adds Two U.S. Patents to Bolster Cardiac Monitoring IP Portfolio - Barchart.com

May 06, 2025
pulisher
May 06, 2025

HeartBeam (BEAT) Expands IP Portfolio with New U.S. Patents | BEAT Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio - Business Wire

May 06, 2025
pulisher
May 05, 2025

HeartBeam Expands Board with CEO Robert Eno’s Appointment - citybuzz -

May 05, 2025
pulisher
May 05, 2025

HeartBeam (NASDAQ: BEAT) Appoints CEO Robert Eno To Board Of Directors - Barchart.com

May 05, 2025
pulisher
May 05, 2025

HeartBeam (BEAT) Welcomes CEO Robert Eno to Its Board of Directo - GuruFocus

May 05, 2025
pulisher
May 05, 2025

HeartBeam Appoints CEO Robert Eno to Board - TipRanks

May 05, 2025
pulisher
May 05, 2025

HeartBeam expands board, appoints CEO to director role By Investing.com - Investing.com India

May 05, 2025
pulisher
May 05, 2025

HeartBeam expands board, appoints CEO to director role - Investing.com Australia

May 05, 2025
pulisher
May 05, 2025

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth - Bluefield Daily Telegraph

May 05, 2025
pulisher
May 05, 2025

HeartBeam, Inc. Appoints Robert Eno to Board of Directors - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

HeartBeam CEO Robert Eno joins company’s board as commercialization nears - Medical Economics

May 05, 2025
pulisher
May 02, 2025

HeartBeam (NASDAQ: BEAT) Prices $10 Million Public Offering At $1.70 Per Share - Barchart.com

May 02, 2025
pulisher
May 01, 2025

HeartBeam (NASDAQ: BEAT) to Report Q1 2025 Results and Provide Business Update on May 13 - Barchart.com

May 01, 2025
pulisher
May 01, 2025

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time - Bluefield Daily Telegraph

May 01, 2025
pulisher
May 01, 2025

HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosis - Yahoo Finance

May 01, 2025
pulisher
Apr 30, 2025

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology - BioSpace

Apr 30, 2025
pulisher
Apr 29, 2025

Strategic Collaboration with AccurKardia for Ambulatory ECG - openPR.com

Apr 29, 2025
pulisher
Apr 29, 2025

Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) - The Globe and Mail

Apr 29, 2025
pulisher
Apr 29, 2025

Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) | FinancialContent - FinancialContent

Apr 29, 2025

Heartbeam Inc Azioni (BEAT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Heartbeam Inc Azioni (BEAT) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Cruickshank Tim
CFO
Feb 14 '25
Buy
1.70
17,647
30,000
17,647
de Urioste George
Director
Sep 06 '24
Sale
2.34
1,674
3,917
57,146
de Urioste George
Director
Aug 30 '24
Sale
2.31
5,500
12,705
58,820
de Urioste George
Director
Aug 27 '24
Sale
2.26
2,194
4,958
64,320
de Urioste George
Director
Aug 23 '24
Sale
2.30
2,500
5,750
66,814
de Urioste George
Director
Aug 26 '24
Sale
2.38
300
714
66,514
$21.12
price up icon 0.76%
$11.33
price down icon 1.39%
$22.11
price up icon 0.87%
$46.63
price up icon 4.53%
$22.12
price up icon 0.55%
health_information_services WAY
$39.34
price up icon 1.73%
Capitalizzazione:     |  Volume (24 ore):